Clinical Trial Update: A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) [Phase 2]

View source ↗

Summary

MoonStone is a Phase 2 study of obexelimab for relapsing multiple sclerosis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Obexelimab (obexelimab)

Snippet

Sponsor: Zenas BioPharma (USA), LLC | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING